Gregory Fox, DO
Family Medicine · Gautier, MSNPI 1427230713
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 815 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 815 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Johnson & Johnson$1K
- Alkermes, Inc.$934
- Otsuka America Pharmaceutical, Inc.$901
- plus $5K from 17 others
What the payments were for
- Food & beverage$13,65095%
- Education$6525%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 207 | $2,703 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 106 | $2,377 |
| Teva Pharmaceuticals USA, Inc. | 85 | $1,617 |
| Johnson & Johnson | 51 | $1,009 |
| Alkermes, Inc. | 34 | $934 |
| Otsuka America Pharmaceutical, Inc. | 39 | $901 |
| Lundbeck LLC | 53 | $863 |
| Supernus Pharmaceuticals, Inc. | 32 | $607 |
| Vanda Pharmaceuticals Inc. | 21 | $537 |
| Sunovion Pharmaceuticals Inc. | 52 | $464 |
| Indivior Inc. | 18 | $425 |
| Neurocrine Biosciences, Inc. | 22 | $409 |
| Axsome Therapeutics, Inc. | 25 | $393 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $331 |
| E.r. Squibb & Sons, L.L.C. | 5 | $143 |
| Tris Pharma Inc | 1 | $125 |
| Almatica Pharma LLC | 7 | $125 |
| Idorsia Pharmaceuticals US Inc | 1 | $92 |
| Avanir Pharmaceuticals, Inc. | 5 | $73 |
| Amgen | 4 | $65 |
| Corium, LLC | 3 | $60 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Orexo US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$1,000
- LYBALVI$868
- CAPLYTA$601
- INVEGA SUSTENNA$263
- ARISTADA INITIO$250
- VRAYLAR$231
- Fanapt$125
- Dyanavel XR$125
- UZEDY$115
- ABILIFY MAINTENA$101
- ABILIFY ASIMTUFII$101
How this compares
$14,302 in reported general payments places this provider in the 95th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 76 | $864,697 |
| Invega SustennaPaliperidone Palmitate | 122 | $358,732 |
| Invega TrinzaPaliperidone Palmitate | 18 | $190,202 |
| Abilify MaintenaAripiprazole | 59 | $160,395 |
| Abilify AsimtufiiAripiprazole | 16 | $87,878 |
| VraylarCariprazine Hcl | 56 | $82,746 |
| AristadaAripiprazole Lauroxil | 11 | $38,642 |
| RexultiBrexpiprazole | 24 | $34,512 |
| AuvelityDextromethorphan Hbr/Bupropion | 29 | $29,581 |
| CaplytaLumateperone Tosylate | 15 | $25,137 |
| TrintellixVortioxetine Hydrobromide | 31 | $16,890 |
| Risperidone ErRisperidone Microspheres | 13 | $14,913 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 53 | $11,362 |
| Lurasidone Hcl | 69 | $9,144 |
| Chlorpromazine Hcl | 24 | $8,535 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,617 | $864,69776 claims |
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $1,009 | $548,934140 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Abilify Asimtufii, Rexulti | $901 | $282,78699 claims |
| AbbVieVraylar | $2,703 | $82,74656 claims |
| Alkermes, Inc.Aristada | $934 | $38,64211 claims |
| Axsome Therapeutics, Inc.Auvelity | $393 | $29,58129 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $2,377 | $25,13715 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $331 | $16,89031 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone | $35 | $11,36253 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Gautier
- Russell CarlisleWesson$1.6M
- Keith StokesLexington$654K
- Walter CarnahanSouthaven$146K
- Karen WhitneyWhitfield$117K
- Dava ClevelandJackson$100K
- Andrea PhillipsJackson$96K
- Kristi TrimmRidgeland$34K
- Tana CooperBiloxi$25K
- Delora DenneyPicayune$24K
- Randall HulingOlive Branch$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.